Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Clinical trial NCT00516828 · COMPLETED
Trial details
- NCT number
- NCT00516828
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-27
- Primary completion
- 2010-03-18
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.